VERA
Vera Therapeutics Inc
30.40$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.2% | -299.8% | – | – | – | |
| – | – | +49.9% | – | – | – | – | – | – | – | -122.7% | – | – | |
| – | +36.3% | +12.4% | +18.8% | +37.5% | -17.3% | +23.8% | +40.7% | -2.8% | +5.5% | +44.4% | -30.1% | – | |
| – | +10.4% | +26.7% | +1.5% | +18.1% | +64.1% | -6.3% | +50.5% | -0.9% | +60.4% | +12.1% | +34.0% | – | |
| – | +27.2% | +15.9% | +16.5% | +33.4% | -1.8% | +16.9% | +39.1% | +5.5% | +13.6% | +31.3% | -10.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.0% | +80.5% | +0.3% | +1.3% | -3.4% | -4.2% | +4.6% | +4.6% | +187.0% | -67.6% | +1.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | -99,627.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.